Saturday, September 25, 2021

Tag: cancer

#VisualAbstract Indatuximab ravtansine in combination with immunomodulatory drugs shows objective and clinical response in patients with relapsed or refractory multiple myeloma

Kathleen Lau -
0
Read more

#Visual Abstract Watchful waiting may be an appropriate strategy for some patients with basal cell carcinomas

Kathleen Lau -
0
Read more

#VisualAbstract Pembrolizumab after CD19-directed CAR T-cell therapy appears safe and may achieve clinical responses in patients with relapsed/refractory B-cell lymphomas

Kathleen Lau -
0
Read more

Physician-directed genetic screening to evaluate personal risk for medically actionable disorders

Davy Lau -
0
1. 15.5% of individuals undergoing primary genetic risk screening testing positive for a genetic variant associated with a preventable monogenic disorder. 2. 49.8% of individuals who tested positive had a variant associated with hereditary cancer. Evidence Rating Level: 2 (Good) Typically, genetic risk screening for healthy individuals is used mainly in preconception...
Read more

#VisualAbstract Brentuximab vedotin with nivolumab was well-tolerated and showed durable remissions as initial salvage therapy in relapsed/refractory classic Hodgkin’s Lymphoma

Kathleen Lau -
0
Read more

#VisualAbstract Use of Current Procedural Terminology (CPT) billing codes may serve as a valid proxy for estimating the prevalence of skin cancers

Kathleen Lau -
0
Read more

#VisualAbstract Vitamin K antagonists did not increase the risk of myelodysplastic syndrome in patients with non-valvular atrial fibrillation

Kathleen Lau -
0
Read more

#VisualAbstract Underlying multiple myeloma remains the primary cause of death across all age groups of patients and across all lines of therapy

Kathleen Lau -
0
Read more

#VisualAbstract Patients with follicular lymphoma experience a plateau in therapy initiation rates during their first decade of observation after diagnosis

Kathleen Lau -
0
Read more

#VisualAbstract Addition of daratumumab to standard of care improves minimal residual disease negativity in patients with newly diagnosed, transplant-ineligible multiple myeloma

Kathleen Lau -
0
Read more
123...15Page 1 of 15
© Copyright 2 Minute Medicine, Inc. All rights reserved.